Topical tacrolimus for the treatment of lichen simplex chronicus.
J Dermatolog Treat
; 18(2): 115-7, 2007.
Article
en En
| MEDLINE
| ID: mdl-17520470
ABSTRACT
Owing to severe itching and scratching, the natural course of lichen simplex chronicus (LSC) is clinically characterized by typical lichenoid lesions. Topical corticosteroids are often used to treat LSC but after withdrawal a relapse will sometimes occur. Therefore, LSC can be difficult to treat over time. We report a 13-year-old boy suffering from LSC on two symmetrical circumscribed areas on the temple, whose lesions healed completely with tacrolimus 0.1% ointment within approximately 9 months. During active treatment no adverse drug reaction was observed. The patient is completely free of symptoms 3 years after cessation of treatment. We conclude that topical tacrolimus can be used as an effective, long-lasting therapeutic modality in treating LSC, especially in sensitive skin areas such as the face.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Tacrolimus
/
Dermatosis Facial
/
Inmunosupresores
/
Neurodermatitis
Tipo de estudio:
Diagnostic_studies
Límite:
Adolescent
/
Humans
/
Male
Idioma:
En
Año:
2007
Tipo del documento:
Article